Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Terns Pharmaceuticals, Inc. | Director | Common Stock | 476K | $5M | $10.50 | Sep 12, 2024 | Indirect |
Zenas BioPharma, Inc. | Director | Common Stock | 58.8K | $1M | $17.00 | Sep 13, 2024 | Indirect |
ARROWHEAD PHARMACEUTICALS, INC. | Director | Common Stock | 33.7K | $926K | $27.50 | Mar 20, 2024 | Direct |
Zenas BioPharma, Inc. | Director | Stock Option (Right to Buy) | 37K | Sep 12, 2024 | Direct | ||
Terns Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 4.68K | Jul 1, 2024 | Direct |